Benutzer: Gast  Login
Titel:

Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.

Dokumenttyp:
Controlled Clinical Trial; Journal Article; Article
Autor(en):
Abbrederis, K; Lorenzen, S; Rothling, N; Ihbe-Heffinger, A; Schuster, T; Peschel, C; Lordick, F
Abstract:
BACKGROUND: Chemotherapy-induced nausea and vomiting (CINV) belongs to the most feared side-effects of cancer treatment. Its incidence during chemotherapy of gastrointestinal tumors (GITs) with highly and moderately emetogenic regimens is not well documented. It is also unknown whether aprepitant, a neurokinin-1 receptor antagonist, can be used as secondary antiemetic prophylaxis in case of CINV during cycle 1. PATIENTS AND METHODS: Patients with GITs who were treated with highly and moderately...     »
Zeitschriftentitel:
Onkologie
Jahr:
2009
Band / Volume:
32
Heft / Issue:
1-2
Seitenangaben Beitrag:
30-4
Sprache:
eng
Volltext / DOI:
doi:10.1159/000183735
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/19209016
Print-ISSN:
0378-584X
TUM Einrichtung:
Frauenklinik und Poliklinik; III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Medizinische Statistik und Epidemiologie
 BibTeX